Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,01 USD | -0,99% | -4,07% | -83,86% |
14/05 | RAPT THERAPEUTICS, INC. : Wolfe Research verlaagt advies naar Neutraal | ZM |
10/05 | RAPT THERAPEUTICS, INC. : Guggenheim verlaagt advies naar Neutraal | ZM |
Vakgebied
Aantal werknemers: 126
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 01-08-15 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 02-12-19 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 04-05-22 |
William Ho
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-05-15 |
Dirk Brockstedt
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-01-18 |
Nipun Davar
CTO | Chief Tech/Sci/R&D Officer | - | 13/02 |
Investor Relations Contact | 63 | - | |
General Counsel | - | 03-05-23 | |
Adnan Rahman
PRN | Corporate Officer/Principal | - | 28-09-22 |
Shari L. Geffon
PRN | Corporate Officer/Principal | - | 04-05-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 04-12-19 |
William Rieflin
CHM | Chairman | 64 | 01-05-15 |
Wendye Robbins
BRD | Director/Board Member | 63 | 22-10-19 |
Brian Wong
CEO | Chief Executive Officer | 52 | 01-08-15 |
Michael Giordano
BRD | Director/Board Member | 66 | 01-01-18 |
Linda Kozick
BRD | Director/Board Member | 66 | 01-12-16 |
Director/Board Member | 46 | 09-11-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 34 799 702 | 32 933 918 ( 94,64 %) | 0 | 94,64 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-83,86% | 140 mln. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |
- Beurs
- Aandelen
- Koers RAPT
- Onderneming RAPT Therapeutics, Inc.